QuidelOrtho Corporation (QDEL) Q4 2024 Earnings Call Transcript
QuidelOrtho Corporation (NASDAQ:QDEL) Q4 2024 Results Conference Call February 12, 2025 5:00 PM ET
Company Participants
Juliet Cunningham – Vice President, Investor Relations
Brian Blaser – President and Chief Executive Officer
Joe Busky – Chief Financial Officer
Conference Call Participants
Jack Meehan – Nephron Research
Patrick Donnelly – Citi
Bill Bonello – Craig-Hallum
Lu Li – UBS
Andrew Cooper – Raymond James
Casey Woodring – JPMorgan
Andrew Brackmann – William Blair
Jose Ricardo – RBC Capital Markets
Operator
Welcome to the QuidelOrtho Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast. At this time, all participant lines are in a listen-only mode. [Operator Instructions]
I would now like to turn the call over to Juliet Cunningham, Vice President of Investor Relations.
Juliet Cunningham
Thank you. Good afternoon, everyone.
Thanks for joining the QuidelOrtho’s fourth quarter and full year 2024 financial results conference call. With me today are Brian Blaser, President and Chief Executive Officer; and Joe Busky, Chief Financial Officer. This conference call is being simultaneously webcast on the Investor Relations page of our website. To aid in the discussion, we posted a supplemental presentation on the IR page that will be referenced throughout this call.
This conference call contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not strictly historical, including the company’s expectations, plans, financial guidance, future performance, and prospects, are forward-looking statements that are subject to certain risks and uncertainties, assumptions, and other factors.
Actual results may vary materially from those expressed or implied in these forward-looking statements. Information about potential factors that could affect our actual results is available on our annual report on Form 10-K for the 2023 fiscal year and subsequent reports filed with the SEC, including the Risk Factors section.
Forward
